Navigation Links
Lucid's VivaScope(R) Reflective Confocal Microscope Approved for Sale in China
Date:3/24/2008

ROCHESTER, N.Y., March 24 /PRNewswire/ -- China's State Food and Drug Administration has approved the sale of the pioneering Lucid VivaScope(R) reflective confocal microscope in the Peoples Republic of China, said Jay Eastman, CEO of Lucid, a Rochester, New York-based medical device and information company dedicated to providing improved care for dermatology patients.

Lucid's VivaScope(R) reflective confocal microscopes (RCM) provide non- invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need for surgery to excise tissue -- thus improving the quality of care for their patients.

"Just as MRI and CT scans have largely eliminated the need for routine 'exploratory surgery', the use of Lucid's VivaScope(R) confocal microscopes may one day eliminate the need for routine invasive skin biopsies," Eastman explained.

"This milestone announcement opens opportunities for application of confocal microscopes to evaluate and monitor treatment of skin inflammatory and pigmentation disorders with leading hospitals throughout China," Eastman said.

"I am very pleased to see this positive outcome from a long and detailed review process that will allow us to participate in one of the fastest growing medical markets in the world," he said. "We believe that reflectance confocal microscopes will become a standard clinical tool with its capacity to take painless, non-invasive optical biopsies of a wide range of skin lesions and disorders."

Sales of Lucid's VivaScope(R) confocal microscopes in China will be handled by ConBio (China) Co., Ltd, Eastman said.

Dr. Qiushi Ren, CEO, ConBio said, "We are excited by the opportunity to introduce Lucid's unique, leading RCM technology to Chinese doctors and building our business together."

Founded in 1996, ConBio is a multi-specialty health care company focused on providing innovative
'/>"/>

SOURCE Lucid, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy
2. Nikon Instruments Launches Fully-Automated A1 Confocal Laser Microscope Series
3. Nikon Instruments New NIS-Elements C Delivers Comprehensive Confocal and Widefield Imaging Capabilities in Single Unifying Software Platform
4. Nikon Instruments Launches New Eclipse Ti-E Fully-Integrated, Motorized Inverted Microscope
5. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
6. All done with mirrors: NIST microscope tracks nanoparticles in 3-D
7. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
8. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
9. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
10. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
11. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  Technology Applications International ... that its wholly-owned subsidiary Renuell Int,l, Inc. has signed ... and Space Administration ("NASA") at the Johnson Space Center ... See photos: tapplic.com/houstonphotos/ ... are very pleased to announce our latest, exclusive agreement ...
(Date:9/2/2014)... September 02, 2014 Opertech Bio, ... highly efficient, cost effective approach to sensory evaluation, ... 8,820,265 by the U.S. Patent and Trademark Office, ... , “Opertech’s taste evaluation technology called ... automated high throughput system for rapid characterization of ...
(Date:9/2/2014)... 2, 2014  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, ... the appointment of Debra Zack , M.D., ... of Lloyd Rowland , senior vice president, ... "Debra,s expertise in biologics clinical development and ...
(Date:9/2/2014)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... targeting specific pathogens that cause serious infections and ... preclinical toxicology study of SYN-004. Per U.S. Food ... was required to move the Company,s lead anti-infective, ... effects of Clostridium difficile (C. difficile), ...
Breaking Biology Technology:Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3Opertech Bio Receives U.S. Patent for High-Throughput Taste Evaluation Technology 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 2Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 4Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 5
... Micromet, Inc. (Nasdaq: ... for the treatment of cancer, inflammation and autoimmune diseases, ... Itin, will present at the Cowen Health Care Conference ... on Tuesday, March 17, 2009. A simultaneous webcast ...
... Company Receives Allowance of Patent Claims in the ... Highlighted in Nature Biotechnology -BRITISH COLUMBIA, Canada, March ... IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com ), a ... monoclonal antibodies based on its Dynamic Cross Linking ...
... Wis., March 6 Mach One Corporation (Pink ... subsidiary, Modular Process Constructors LLC, is changing its ... vision, and announces that it received a contract ... consumer health company. The contract is for a ...
Cached Biology Technology:Micromet to Present at the Cowen Health Care Conference on March 17, 2009 2Micromet to Present at the Cowen Health Care Conference on March 17, 2009 3Micromet to Present at the Cowen Health Care Conference on March 17, 2009 4InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies 2InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies 3Mach One Subsidiary Modular Process Constructors LLC Changes Name to MPS BioPharm to Better Reflect its Vision 2
(Date:9/2/2014)... with the participation of the University of Granada has ... place in the Iberian Peninsula around the mid Holocene ... dust coming from the Sahara increased. The data came ... Alpine lake in Sierra Nevada (Granada) , This study, ... based on the sedimentation of atmospheric dust from the ...
(Date:9/2/2014)... ideal source of nutrition for infants and it ... evolution and civilizations of human beings. Unlike our ... of bacterial species, including some opportunistic pathogens of ... scientists and physicians. , Indeed, the existence of ... of co-evolutionary and co-adaptive interactions between the microbiome ...
(Date:9/2/2014)... 2014 A study published in the September ... American Academy of Child and Adolescent Psychiatry ... psychiatric diagnosis had an increased risk of developing ... Using data from the nationwide Danish registers, a ... Nielsen, Psychiatry, Aalborg University Hospital, Denmark, studied 48,299children ...
Breaking Biology News(10 mins):Scientists obtain new data on the weather 10,000 years ago from sediments of a lake in Sierra Nevada 2Are human breast milk microbiome 'neutral'? 2Are human breast milk microbiome 'neutral'? 3Risk of diabetes in children and adolescents exposed to antipsychotics 2
... for many people with depression and anxiety disorders, and ... care providers, according to researchers who analyzed the results ... shown to have tremendous benefits for mental health," says ... Program at Southern Methodist University in Dallas. "The more ...
... at Ume University and the Sahlgrenska Academy at the University ... can be found in fish that have been swimming in ... found in higher concentrations in the blood of fish than ... this hormone can lead to infertility in fish. The ...
... neurodegenerative disease spinocerebellar ataxia type 5 (SCA5) damages nerve ... report that the defective protein responsible for the disease ... inside neurons. The study appears in the April 5 ... ( www.jcb.org ). SCA5 results from a faulty ...
Cached Biology News:Mental health providers should prescribe exercise more often for depression, anxiety 2Medicine residues may threaten fish reproduction 2Defective protein is a double hit for ataxia 2
... QRT-PCR Mixes are formulated for use in ... SYBR Green. One-step QRT-PCR mixes offer a ... The pipetting steps are minimised, making the ... ,The 2x ABsolute QRT-PCR Mix is supplied ...
... of environmental and pathophysiological stressful conditions trigger ... known as heat shock proteins (HSPs), more ... The Hsp90 family of proteins in ... beta, Grp94, and Trap-1 (Hsp75). It was ...
... bespoke, cost-effective solutions for complex protein processing and production ... experience to help you develop a solution to your ... , do ... transfer all methodology to your own ...
... The Schleicher & Schuell BioScience Arraying ... dedicated to custom protein and nucleic ... project teams, comprised of R&D, Engineering, ... closely with collaborators every step of ...
Biology Products: